Skip to content

Biofarmaatsia OÜ

Registry code (registrikood) 12787873Private limited company (Osaühing)VAT EE101871280Activity (EMTAK 46901): Spetsialiseerimata hulgikaubandusActive

Tallinn, Harju County · Financial data: annual reports up to 2025; tax data up to 2026 Q3

Revenue (2025)
€1.1M
▲ 3.8% vs 2024
Profit before tax (2025)
€133k
Employees, FTE (2025)
3
State taxes paid, last 4 quarters
€213k

Revenue, profit and employees, 2019–2025

€84k2019€376k2020€813k2021€761k2022€1.2M2023€1.1M2024€1.1M2025
YearRevenue (müügitulu)Operating profit (ärikasum)Net profitEquity (omakapital)Employees, FTE
2019€84,065-€54,856-€54,856-€36,1664
2020€376,220€90,749€90,749€54,5834
2021€813,066€24,962€27,408€81,9914
2022€761,245€13,898€16,091€98,0824
2023€1,189,426€185,306€189,670€287,7522
2024€1,082,866€71,968€84,290€372,0423
2025€1,123,558€120,291€133,256€505,2983

Balance sheet summary

YearCashTotal assetsCurrent liabilitiesNon-current liabilitiesEquity
2019€7,485€78,529€114,695—-€36,166
2020€14,367€449,165€394,582—€54,583
2021€13,470€314,731€201,793€30,947€81,991
2022€24,547€321,881€200,824€22,975€98,082
2023€4,793€573,623€271,069€14,802€287,752
2024€59,227€619,984€241,519€6,423€372,042
2025€189,056€856,215€350,917€0€505,298

Calculated ratios

Net profit margin = net profit ÷ revenue. Equity ratio = equity ÷ total assets. Seedata sources & methodology for how each figure is derived.

Quarterly tax and turnover data (EMTA)

QuarterState taxes paidWage taxesTurnoverEmployees
2022 Q1€24,809€12,250€237,8374
2022 Q2€18,554€12,216€152,7834
2022 Q3€22,668€9,287€197,2505
2022 Q4€30,585€11,334€246,0805
2023 Q1€35,421€13,213€437,9125
2023 Q2€30,900€11,913€350,5574
2023 Q3€25,627€9,801€271,0444
2023 Q4€31,553€10,201€331,4453
2024 Q1€34,384€10,129€358,4564
2024 Q2€35,171€11,863€285,8004
2024 Q3€32,923€14,144€269,8304
2024 Q4€47,013€14,915€348,4904
2025 Q1€51,327€16,452€384,8924
2025 Q2€48,838€16,900€323,3504
2025 Q3€42,192€13,202€308,9474
2025 Q4€59,818€14,969€421,8994
2026 Q1€55,241€16,009€504,1744
2026 Q2€57,303€16,508€423,1254
2026 Q3€40,182€14,032€287,6263

Source: EMTA quarterly published data, as of 10 October 2026. Covers state taxes and wage taxes actually paid and turnover and employee counts as declared by the company, not the annual report figures above.

About this data

In the 2025 financial year (period 1 January 2025–31 December 2025), Biofarmaatsia OÜ reported revenue of €1,123,558.

The company closed the 2025 financial year with a net profit of €133,256.

Revenue increased by 3.8% from €1,082,866 in 2024 to €1,123,558 in 2025.

Revenue grew at a compound annual rate of 54.1% between 2019 and 2025.

Equity accounted for 59.0% of total assets of €856,215 at the end of the 2025 reporting period.

With 3 full-time-equivalent employees in 2025, revenue per employee was €374,519.

Across the 4 most recent quarters declared to EMTA, up to Q3 2026, Biofarmaatsia OÜ reported €1,636,824 in turnover.

EMTA recorded 3 employees for the quarter ending Q3 2026, compared with 3 full-time-equivalent employees in the 2025 annual report.

Browse

Source

Source: Estonian e-Business Register open data (Centre of Registers and Information Systems, RIK), licence CC BY-SA 4.0, modified; Estonian Tax and Customs Board (EMTA) quarterly data. Downloaded 2026-11-16. This is not an official register extract — see ariregister.rik.ee.

Company data on this site is available under CC BY-SA 4.0.

To request a correction or the removal of this page, use the contact form. Removal requests are handled within 30 days, no justification required.